abstract |
The invention relates to compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, X and X' which have the meaning cited in claim 1, are tyrosine kinase inhibitors, in particular TIE-2, and Raf-kinases, and can also be used in the treatment of tumours. |